A Triazacyclononane-Based Bifunctional Phosphinate Ligand for the Preparation of Multimeric 68Ga Tracers for Positron Emission Tomography

A Triazacyclononane-Based Bifunctional Phosphinate Ligand for the Preparation of Multimeric 68Ga Tracers for Positron Emission Tomography
复制标题

DOI:
10.1002/chem.200903281
复制
发表时间:
2010-01-01
影响因子:
4.3
通讯作者:
Lukes, Ivan
Lukes, Ivan
中科院分区:
化学2区
文献类型:
--
作者:
Notni, Johannes;Hermann, Petr;Lukes, Ivan

文献摘要

被引文献

相似文献

用于正电子发射断层扫描(PET)。PrP 9是一种具有甲基(2-羧乙基)次膦酸侧臂的N,N ',N“-三取代三氮杂环壬烷,可作为Ga-68(3+)的配位剂。合成过程短,成本低。Ga-III和Fe-III配合物的PrP 9,其特征在于通过单晶X-射线衍射。用电位法测定了金属配合物的逐步质子化常数和热力学稳定性。Ga-Ⅲ配合物具有较高的热力学稳定性(log K-[GaL]=26.24)和较高的动力学惰性。PrP 9的Ga-68标记可以在环境温度和宽pH范围内进行,甚至在低至1的pH值下进行。这意味着第一次,基于TiO 2的Ge-68/Ga-68发生器(通常由0.1m HCl组成)的纯固体可直接用于标记目的。在pH 3.3和20 ℃下Ga-68活性掺入的速率高于已建立的螯合剂DOTA和NOTA。合成了PrP 9与氨基酸酯的三酰胺,以作为多聚体肽缀合物的模型。这些缀合物表现出与未取代的PrP 9类似的放射性标记性质。
For application in positron emission tomography (PET). PrP9, a N,N',N ''-trisubstituted triazacyclononane with methyl(2-carboxyethyl)phosphinic acid pendant arms, was developed as Ga-68(3+) complexing agent. The synthesis is short and inexpensive. Ga-III and Fe-III complexes of PrP9 were characterized by single-crystal X-ray diffraction. Stepwise protonation constants and thermodynamic stabilities of metal complexes were determined by potentiometry. The Ga-III complex possesses a high thermodynamic stability (log K-[GaL]=26.24) and a high degree of kinetic inertness. Ga-68 labeling of PrP9 is possible at ambient temperature and in a wide pH range, also at pH values as low as 1. This means that for the first time, the neat eluate of a TiO2-based Ge-68/Ga-68 generator (typically consisting of 0.1m HCl) can be directly used for labeling purposes. The rate of Ga-68 activity incorporation at pH 3.3 and 20 degrees C is higher than for the established chelators DOTA and NOTA. Tris-amides of PrP9 with amino acid esters were synthesized to act as models for multimeric peptide conjugates. These conjugates exhibit radiolabeling properties similar to those of unsubstituted PrP9.